Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Patients With Prostate Cancer.Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorderNot yet recruitingPhase 32025-04-13NCT06922903

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Yunhe Pharmaceutical (Tianjin) Co., Ltd3

32 results · Page 1 of 2

Swipe the table sideways for more columns.